Dermal Filler

Differentiated Dermal Filler Opportunity

N8 Medical is pursuing a novel, enhanced dermal filler product with ceragenins incorporated, designed to address key concerns in the dermal filler market.

  • Hyaluronic acid (HA) dermal fillers represent a significant and growing global market opportunity (≈$2B in 2018) that is a private pay market with relatively undifferentiated products
  • Many patients experience inflammation that delays healing and recovery, and associated pain
  • Biofilm growth on HA dermal fillers is an emerging concern among clinicians
  • N8 Medical’s enhanced ceragenin-infused dermal filler reduced inflammation associated with dermal filler injections in pilot study, with no safety issues observed
  • N8 Medical’s enhanced ceragenin-infused dermal filler is designed to:*
    • Reduce inflammation
    • Enhance appearance
    • Reduce infection and biofilm risk
*CAUTION: IN THE UNITED STATES, THE REFERENCED PRODUCT HAS NOT BEEN GRANTED MARKETING APPROVAL BY FDA, AND IS NOT AVAILABLE FOR COMMERCIAL SALE. THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION.